MétaCan
Menu
Back to cohort
Record W2018097894 · doi:10.1016/j.bbmt.2006.12.364

359: Outcome of matched sibling donor hematopoietic stem cell transplantation for standard risk pediatric acute myelogenous leukemia in first complete remission

2007· article· en· W2018097894 on OpenAlexaffabout
Adam Gassas, Sina Afzal, M. Kashif Ishaqi, John Doyle

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2007
Typearticle
Languageen
FieldMedicine
TopicAcute Myeloid Leukemia Research
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMedicineTotal body irradiationHematopoietic stem cell transplantationCyclophosphamideMelphalanTransplantationInternal medicineLeukemiaChemotherapySurgeryBusulfanOncologyPediatrics

Abstract

fetched live from OpenAlex

In recent years there has been a significant improvement in the outcome of children with standard risk acute myelogenous leukemia (AML) treated with chemotherapy only. In the MRC-UK trials 10 and 12, standard risk AML children were allowed to proceed to hematopoietic stem cell transplantation (HSCT) if there is a full matched family donor. However, with the excellent results of chemotherapy and the known risks and long term effects of HSCT, this decision remains controversial. Herein, our objective was to review the outcome of all children between 1995-2005 with standard risk AML who received a matched sibling donor (MSD) in CR1 in our institution and compare their outcome with the published MRC-UK results. Standard risk features were defined according to the MRC-UK criteria. Thirty-two consecutive children (16 males:16 females) received MSD HSCT between 1995-2005 at the Hospital for Sick Children, Toronto. Median age was 8.4 years (range 0.5-17.5 years). Conditioning regimens included; busulphan/cyclophosphamide (Bu/Cy) n=23; Cy/Total body irradiation (TBI) n=4, VP16/TBI n=4 and Bu/Melphalan (Bu/Mel) n=1. Graft-versus-host disease (GVHD) prophylaxis was with cyclosporine A and a short course of methotrexate. All patients engrafted apart from one patient who was conditioned with VP16/TBI and suffered a primary graft failure. That patient was re-conditioned with Bu/Cy/ATG and successfully engraft and still alive 6 years post the second HSCT. Acute grade I-II and grade III-IV GVHD occurred in 6 and 1 patients, respectively. Chronic GVHD affected 3 patients, limited in 2 and extensive in 1. One patient died from transplant related mortality (TRM). Eight patients relapsed and six died from their disease. Two relapsed patients received a second HSCT and continue to be in remission for 8 and 55 months, respectively. For a median follow up of 52 months (range 6-104 months), the relapse free survival (RFS) is 75% and the event free survival (EFS) including the 2 patients who received the second HSCT is 81%. Larger studies such as the MRC-UK 10 and 12 reported 63% RFS. Conclusion: Outcome of children with standard risk AML transplanted from a MSD in CR1 is very encouraging with minimal toxicity. HSCT for standard risk patient with an available family donor should be recommended.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.287
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2007
Admission routes2
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicAcute Myeloid Leukemia ResearchFrench-language works237,207